Salvia BioElectronics (Series B)
Funding Details
- Awarder
- RSS - techfundingnews.com
- Date Award
- May 27, 2025
- Vertical
- Medtech
- Funding URL
- View Funding Page
- Funding Amount:
- $60,000,000
Company Info
- Founding Year
- 2017
- Traction
- Salvia has raised over $90 million in total funding and is advancing clinical development with the support of leading investors.
- Founders
- Hubert Martens, Daniel Schobben, Wim Pollet
- Company Description
- Salvia BioElectronics is a clinical-stage medical device company pioneering neuromodulation therapy for chronic migraine patients. Their ultra-thin implant targets key nerves involved in migraine, aiming to reduce both the frequency and intensity of attacks.
- Market
- Chronic migraine treatment
- Location
- UK
- Coinvestors
- Innovation Industries, Invest-NL, EIC Fund, Inkef, Panakès Partners, SHS Capital, Dolby Family Ventures, BOM, Thuja Capital